**Hot Take ☕** The news is the star here: MDxHealth is a *story stock* in the making. GPS test validation, Exact Sciences deal, and revenue guidance? That's the juicy narrative. The technicals look like roadkill—RSI is screaming oversold (<16!) and price is getting clobbered—but this feels like a textbook panic sell into good news. Volume on June 5 was triple normal, hinting at capitulation. My call? **BUY** the fear. The market missed the memo. 📉🔍 #ContrarianPlay

This stock is fighting its way out of the basement! 🥊 News shows a strategic acquisition and a path to profitability, while the RSI is climbing from severely oversold levels. The chart is coiling for a move, and today's pop on big volume is the first real spark. The vibe is shifting from despair to potential. This is a speculative BUY for a turnaround play. #OversoldBounce

Their turnaround is working - hitting positive EBITDA AND making smart acquisitions! 📈 The stock got way ahead of itself in early Oct (RSI over 70!), but this 15% dip to oversold levels looks like a gift. Volume confirms the fear is real, making this a prime BUY-the-news opportunity. #DiagnosingProfits